Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

Representing Sandoz in class actions respecting several pharmaceutical products, including Pioglitazone (Brand product-Actos)

Fasken
Reading Time 1 minute read Subscribe
Client

Sandoz

Sandoz is a generic drug manufacturer. Sandoz was sued, along with Takeda and Apotex, in a putative class action relating to the name brand drug, Actos, and its generic equivalent, Pioglitazone. The drug is designed to treat Type 2 diabetes. The plaintiffs allege that it has an undisclosed adverse side effect of causing bladder cancer. The defendants firmly deny this allegation, and substantial expert evidence ins support of the defendants’ position was filed with court for the certification motion, which has not yet been heard. This matter is important because, among other things, the two generic defendants have raised issues resecting novel defences to the “failure to warn” claim.

    Subscribe

    Receive email updates from our team

    Subscribe